Press Release Archive

Welcome to the press release archive for the ECOG-ACRIN Cancer Research Group. This section of the website provides a comprehensive listing of past press releases in a central location, ordered by date.

We welcome inquiries from members of the press regarding the information posted on this website. To place a media inquiry, contact the Office of Communications.


July 23, 2026
July 23, 2026
Categories

Press Release: Proactive support to quit tobacco use during cancer treatment doubles quit rates in a nationwide trial

Do you like it?
Read more
July 15, 2026
July 15, 2026
Categories

Press Release: ECOG-ACRIN ENDURANCE trial findings published in the New England Journal of Medicine provide the first randomized evidence on the optimal duration of lenalidomide maintenance for patients with newly diagnosed multiple myeloma

Do you like it?
Read more
June 10, 2026
June 10, 2026
Categories

Press Release: Elsa Anagnostou, Jordan Berlin, and Olisaemeka Ogbue receive ECOG-ACRIN 2026 scientific leadership and mentorship awards

Do you like it?
Read more
May 21, 2026
May 21, 2026
Categories

Press Release: Guide to ECOG-ACRIN cancer research at ASCO 2026

Do you like it?
Read more
May 19, 2026
May 19, 2026
Categories

Press Release: TAILORx and RxPONDER trials shift to a discovery platform for analyzing breast cancer recurrence using advanced tumor profiling and AI

Do you like it?
Read more
March 19, 2026
March 19, 2026
Categories

Press Release: ECOG-ACRIN completes enrollment for 600-patient clinical trial focused on frontline treatment for advanced melanoma

Do you like it?
Read more
March 4, 2026
March 4, 2026
Categories

Press Release: ECOG-ACRIN Cancer Research Group announces the retirement of Robert Gray after 25 years as group statistician

Do you like it?
Read more
December 11, 2025
December 11, 2025
Categories

Press Release: An ECOG-ACRIN imaging study solves a long-standing gap in metastatic breast cancer research and care: accurately measuring treatment response in patients with bone metastases

Do you like it?
Read more
December 10, 2025
December 10, 2025
Categories

Press Release: ECOG-ACRIN and Caris Life Sciences unveil first findings from a multi-year collaboration to advance AI-powered multimodal tools for breast cancer recurrence risk stratification

Do you like it?
Read more
November 20, 2025
November 20, 2025
Categories

Guide to SABCS 2025: ECOG-ACRIN research at the world’s largest breast cancer conference

Do you like it?
Read more
November 18, 2025
November 18, 2025
Categories

Guide to ASH 2025: ECOG-ACRIN and PrECOG are set to reveal multiple blood cancer research discoveries

Do you like it?
Read more
October 20, 2025
October 20, 2025
Categories

Press Release: Immunotherapy after surgery shows potential in preventing the spread of aggressive skin cancer

Do you like it?
Read more
June 24, 2025
June 24, 2025
Categories

Press Release: Official BRACELET-1 trial results indicate that adding the oncolytic virus immunotherapy pelareorep to paclitaxel chemotherapy warrants further investigation in HR+ HER2- metastatic breast cancer

Do you like it?
Read more
June 1, 2025
June 1, 2025
Categories

Press Release: Pre-operative THP leads to a pCR in two-thirds of early-stage HER2+ ER- breast cancer patients

Do you like it?
Read more
April 24, 2025
April 24, 2025
Categories

Press Release: Estimating complex immune cell structures by AI tools for survival prediction in advanced melanoma

Do you like it?
Read more
January 15, 2025
January 15, 2025
Categories

Press Release: Large-scale TMIST breast cancer screening trial achieves enrollment goal, paving the way for data that provides a precision approach to screening

Do you like it?
Read more
December 12, 2024
December 12, 2024
Categories

Press Release: Adjuvant tamoxifen may reduce recurrence risk for patients with ‘good-risk’ DCIS who forgo radiation

Do you like it?
Read more
December 10, 2024
December 10, 2024
Categories

Press Release: Autologous stem cell transplants do not improve survival for mantle cell lymphoma patients with undetectable MRD, clinical trial shows

Do you like it?
Read more
November 25, 2024
November 25, 2024
Categories

Press Release: Clinical trial finds that adding the chemotherapy pill temozolomide to radiation therapy improves survival in adult patients with a slow-growing type of brain tumor

Do you like it?
Read more
November 25, 2024
November 25, 2024
Categories

Press Release: ECOG-ACRIN adds a late-breaking abstract to its ASH 2024 presentation line-up

Do you like it?
Read more
Load more
Press Release Archive

News

Press Release Archive
Media Contact:
Diane Dragaud, MA
Director of Communications

Send an email

215-789-3631

Tags

Acute lymphoblastic leukemia (ALL) Acute myeloid leukemia (AML) Advocacy Artificial intelligence (AI) Bladder cancer Breast cancer Cancer screening Cancer treatment Chemotherapy Clinical trial ComboMATCH Disparities Gastric cancer Geriatric oncology GI cancer Group meeting Head and neck cancer Health equity Immunotherapy In memory Leadership Leukemia Lung cancer Lymphoma Melanoma Mentorship Multiple myeloma Myeloma NCI-MATCH Pancreatic cancer Personalized screening Precision medicine Precision oncology Prostate cancer Radiology Research results review Sarcoma Skin cancer Social determinants of health Stomach cancer Survivorship Targeted therapy TMIST Treatment trial

 
ECOG-ACRIN Cancer Research Group